Aarti Pharmalabs inaugurates phase 1 of greenfield manufacturing facility
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
EBITDA before special items decreases to €4.08 billion (7.4%)
The 27 greenfield labs across the country ensure timely and accurate reporting
The plant will have installed production capacity of 3,120 MT/month
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
Silica is a proven and highly effective anti-caking agent that has been used for decades
Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years
The net-zero target approval complements the company's near-term emission reduction targets
Subscribe To Our Newsletter & Stay Updated